Ad
FGEN Short Information FibroGen Inc
home / stock / fgen / fgen short
| Twenty Trading Day Totals | |
|---|---|
| Total Shorted Volume | 1,739,119 |
| Total Actual Volume | 14,095,252 |
| Short Trends | |
|---|---|
| Cover Days | 4 |
| Short Days | 14 |
| No Change Days | 2 |
| Averages | |
|---|---|
| Average Short Volume | 86,956 |
| Average Short Percentage | 54.82% |
Is there a FGEN Short Squeeze or Breakout about to happen?
See the FGEN Short Analysis for free Sign up or Login
Powered by Squeeze Report
FGEN Twenty Trading Day's Volume to Short Volume Chart
FGEN Twenty Trading Day Price Chart
FGEN Short Data Results Days
| Stock Date | Open Price | Close Price | High | Low | Total Volume | Short Volume | Short Percentage |
|---|---|---|---|---|---|---|---|
| 2022-08-17 | 14.26 | 12.76 | 14.51 | 14.16 | 514,440 | 74,671 | 76.3804 |
| 2022-08-16 | 14.5 | 12.76 | 14.56 | 14.2 | 519,243 | 54,040 | 29.0233 |
| 2022-08-15 | 14.36 | 12.76 | 14.77 | 14.35 | 424,401 | 67,107 | 78.2251 |
| 2022-08-11 | 14.5 | 12.76 | 14.64 | 13.87 | 743,267 | 146,665 | 64.7839 |
| 2022-08-10 | 14.62 | 12.76 | 14.62 | 14.24 | 677,434 | 89,428 | 52.4329 |
| 2022-08-09 | 13.42 | 12.76 | 14.36 | 13.31 | 916,353 | 241,416 | 79.1154 |
| 2022-08-08 | 14.53 | 12.76 | 14.65 | 14.05 | 516,519 | 56,187 | 53.6361 |
| 2022-08-04 | 12.77 | 12.76 | 14.04 | 12.77 | 817,482 | 64,015 | 25.1661 |
| 2022-08-03 | 12.59 | 12.76 | 13.26 | 12.53 | 1,048,766 | 87,292 | 39.6490 |
| 2022-08-02 | 12.11 | 12.76 | 12.4 | 12.0672 | 344,891 | 53,758 | 72.0047 |
| 2022-08-01 | 12.43 | 12.76 | 12.82 | 12.06 | 520,917 | 36,715 | 57.9183 |
| 2022-07-29 | 12.88 | 12.76 | 12.88 | 12.53 | 849,235 | 166,686 | 80.5281 |
| 2022-07-28 | 12.76 | 12.76 | 13.1 | 12.37 | 601,604 | 86,599 | 66.2513 |
| 2022-07-26 | 12.12 | 12.12 | 12.73 | 12.08 | 104,060 | 57,712 | 53.3388 |
| 2022-07-25 | 12.3 | 12.19 | 12.3 | 11.93 | 707,227 | 57,323 | 62.6604 |
| 2022-07-19 | 12.19 | 12.49 | 12.8498 | 12.19 | 838,212 | 43,970 | 14.5990 |
| 2022-07-18 | 12.22 | 12.09 | 12.66 | 11.99 | 971,346 | 86,335 | 46.8263 |
| 2022-07-15 | 12.28 | 12.22 | 12.36 | 11.97 | 1,190,774 | 114,444 | 66.9142 |
| 2022-07-14 | 12.38 | 12 | 12.38 | 11.85 | 835,799 | 102,031 | 62.5278 |
| 2022-07-13 | 11.76 | 12.47 | 12.5 | 11.71 | 953,282 | 52,725 | 14.3848 |
News, Short Squeeze, Breakout and More Instantly...
Ad
Ad
-
Completed enrollment of LELANTOS-2 Phase 3 study of pamrevlumab in ambulatory patients with Duchenne muscular dystrophy 2Q 2022 revenue of $29.8 million, growth of 22% vs. 2Q 2021 Continued significant roxadustat volume growth in China SAN F...
-
FIBROGEN INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Provides Update of its Investigation of the Officers and Directors of FibroGen, Inc. - FGEN FIBROGEN INVESTIGATION CONTINUED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & F...
-
SAN FRANCISCO, July 25, 2022 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN) will announce its second quarter 2022 financial results on Monday, August 8 after the market close. FibroGen will also conduct a conference call on that day at 5:00 p.m. ET (2:00 p.m. PT) with the investment comm...
Ad
